Yuan Weng

449 total citations
25 papers, 360 citations indexed

About

Yuan Weng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuan Weng has authored 25 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuan Weng's work include MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (4 papers) and Circular RNAs in diseases (4 papers). Yuan Weng is often cited by papers focused on MicroRNA in disease regulation (5 papers), Peptidase Inhibition and Analysis (4 papers) and Circular RNAs in diseases (4 papers). Yuan Weng collaborates with scholars based in China, United States and Fiji. Yuan Weng's co-authors include Ming Cai, Min Yang, Xiaohong Chen, Qingguo Xie, Ning Guo, Donghui Pan, Shineng Luo, Hong Ding, Yuping Xu and Lixin Lang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Analytical and Bioanalytical Chemistry.

In The Last Decade

Yuan Weng

21 papers receiving 357 citations

Peers

Yuan Weng
Carla Strina Italy
Veronica Bonasera Italy
Diana P. English United States
Baoming Mi China
Sinto Sebastian United States
Guadalupe Lorenzatti Hiles United States
B. Martell United States
Kenneth A. Bøtkjær Denmark
Yanjie You China
Maria-Elena Jockovich United States
Carla Strina Italy
Yuan Weng
Citations per year, relative to Yuan Weng Yuan Weng (= 1×) peers Carla Strina

Countries citing papers authored by Yuan Weng

Since Specialization
Citations

This map shows the geographic impact of Yuan Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Weng more than expected).

Fields of papers citing papers by Yuan Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Weng. The network helps show where Yuan Weng may publish in the future.

Co-authorship network of co-authors of Yuan Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Weng. A scholar is included among the top collaborators of Yuan Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Weng. Yuan Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jiaojiao, et al.. (2025). Mitochondrial-related genome-wide Mendelian randomization identifies putatively causal genes in the pathogenesis of sepsis. Surgery. 181. 109150–109150. 3 indexed citations
2.
3.
4.
Yang, Ming, Kui Gu, Changyu Zhou, et al.. (2024). Recombinant Lactococcus lactis secreting FliC protein nanobodies for resistance against Salmonella enteritidis invasion in the intestinal tract. Journal of Nanobiotechnology. 22(1). 629–629. 4 indexed citations
5.
Sun, Jiaojiao, Gang Liu, Yuan Weng, et al.. (2023). Nrf2/PHB2 alleviates mitochondrial damage and protects against Staphylococcus aureus‐induced acute lung injury. SHILAP Revista de lepidopterología. 4(6). e448–e448. 10 indexed citations
6.
Shen, Jian, et al.. (2023). Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.. PubMed. 38(12). 1429–1441. 8 indexed citations
7.
Li, Jinyou, et al.. (2022). Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR‐139‐5p/ITGB8. Thoracic Cancer. 13(9). 1381–1390. 23 indexed citations
8.
9.
Zhu, Jun, et al.. (2021). circSNX6 (hsa_circ_0031608) enhances drug resistance of non-small cell lung cancer (NSCLC) via miR-137. Biochemical and Biophysical Research Communications. 567. 79–85. 9 indexed citations
10.
Li, Hang, Ting Ye, Bin Li, et al.. (2020). Is 99mTc bone scintigraphy necessary in the preoperative workup for patients with cT1N0 subsolid lung cancer? A prospective multicenter cohort study. Thoracic Cancer. 12(4). 415–419. 2 indexed citations
11.
Wang, Fudong, Xiaosong Ge, Zhiqiang Wang, et al.. (2020). Clinical significance and prognosis of supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Annals of Translational Medicine. 8(4). 90–90. 9 indexed citations
12.
Wang, Fudong, Yuan Weng, Jun Zhu, et al.. (2020). A rare case of hepatoid adenocarcinoma in the lung and literature review: case report. 2. 30–30. 1 indexed citations
13.
Wang, Fudong, Yuan Weng, Jun Zhu, et al.. (2019). A Rare Case of Hepatoid Adenocarcinoma in the Lung and Literature Review. 4(1).
14.
Cai, Ming, et al.. (2015). Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma. Cellular Physiology and Biochemistry. 36(3). 1175–1185. 52 indexed citations
15.
Wang, Zhiqiang, Ming Cai, Yuan Weng, et al.. (2014). Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer. Journal of Cancer Research and Clinical Oncology. 141(8). 1353–1361. 27 indexed citations
16.
Guo, Ning, Donghui Pan, Chunjing Yu, et al.. (2013). First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination. Journal of Nuclear Medicine. 54(5). 691–698. 143 indexed citations
17.
Fei, Bojian, L J Alfred, & Yuan Weng. (2013). Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression. World Journal of Surgical Oncology. 11(1). 120–120. 19 indexed citations
18.
Weng, Yuan, et al.. (2013). Matrix Metalloproteinase Activity in Early-Stage Lung Cancer. Oncology Research and Treatment. 36(5). 256–259. 22 indexed citations
19.
Weng, Yuan, Bojian Fei, Ping He, & Ming Cai. (2012). Glutathione-S-Transferase T1 Polymorphism is Associated with Esophageal Cancer Risk in Chinese Han Population. Asian Pacific Journal of Cancer Prevention. 13(9). 4403–4407. 4 indexed citations
20.
Cai, Ming, et al.. (2007). [Correlation of tenascin-C degradation fragment with recurrence and/or metastasis in early non-small-cell lung cancer].. PubMed. 29(7). 518–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Strina Breakdown of academic impact, for papers by Veronica Bonasera Breakdown of academic impact, for papers by Diana P. English Breakdown of academic impact, for papers by Baoming Mi Breakdown of academic impact, for papers by Sinto Sebastian Breakdown of academic impact, for papers by Guadalupe Lorenzatti Hiles Breakdown of academic impact, for papers by B. Martell Breakdown of academic impact, for papers by Kenneth A. Bøtkjær Breakdown of academic impact, for papers by Yanjie You Breakdown of academic impact, for papers by Maria-Elena Jockovich
Rankless by CCL
2026